Description of Accendra Health Inc's Business Segments

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Composition of Accendra Health inc Revenues by Segments


Capitation agreements	5.1 %	of total Revenue
Diabetes	29.59 %	of total Revenue
Sleep therapy	26.59 %	of total Revenue
Home respiratory therapy	15.48 %	of total Revenue
Ostomy	8.18 %	of total Revenue
Wound care	6.28 %	of total Revenue
Urology	4.75 %	of total Revenue
Other	9.14 %	of total Revenue
Commercial payors	78.56 %	of total Revenue
Medicare	20.03 %	of total Revenue
Medicaid	1.41 %	of total Revenue

Q1 three months ended (Mar 31 2026)
Revenues by Business Segments	Revenues (in millions $)	% (of total Revenues)
Capitation agreements	32.00	5.1 %
Diabetes	185.79	29.59 %
Sleep therapy	166.92	26.59 %
Home respiratory therapy	97.18	15.48 %
Ostomy	51.34	8.18 %
Wound care	39.40	6.28 %
Urology	29.79	4.75 %
Other	57.37	9.14 %
Commercial payors	493.21	78.56 %
Medicare	125.72	20.03 %
Medicaid	8.86	1.41 %
Total	627.78	100 %

Q1 three months ended (Mar 31 2026)
Revenue Growth rates by Segment	Y/Y Revenue %	Q/Q Revenue %
Capitation agreements	-46.67 %	-
Diabetes	-0.84 %	-
Sleep therapy	-8.21 %	-
Home respiratory therapy	-10.52 %	-
Ostomy	3.71 %	-
Wound care	-15.53 %	-
Urology	5.85 %	-
Other	-20.07 %	-
Commercial payors	-9.26 %	-
Medicare	4.48 %	-
Medicaid	-11.64 %	-
Total	-	-77.27 %

Q1 three months ended (Mar 31 2026)
Income by Business Segments	Income (in millions $)	% (Profit Margin)
Total	-6.47	-

Q1 three months ended (Mar 31 2026)
Income Growth rates by Segment	Y/Y Income %	Q/Q Income %
Total	-	-

Annual Report on Accendra Health inc Divisions, Sales by Country


Capitation agreements	8.83 %	of total Revenue
Diabetes	28.36 %	of total Revenue
Sleep therapy	26.79 %	of total Revenue
Home respiratory therapy	15.68 %	of total Revenue
Ostomy	7.71 %	of total Revenue
Wound care	6.82 %	of total Revenue
Urology	4.2 %	of total Revenue
Other	10.43 %	of total Revenue
Commercial payors	80.58 %	of total Revenue
Medicare	18.02 %	of total Revenue
Medicaid	1.39 %	of total Revenue

Twelve months ended 2025
ACH s Annual Revenue by Geography and Business Segments	Sales (in millions $)	% (of total Sales)
Capitation agreements	244.00	8.83 %
Diabetes	783.37	28.36 %
Sleep therapy	740.05	26.79 %
Home respiratory therapy	433.05	15.68 %
Ostomy	212.84	7.71 %
Wound care	188.51	6.82 %
Urology	116.02	4.2 %
Other	288.19	10.43 %
Commercial payors	2,225.78	80.58 %
Medicare	497.80	18.02 %
Medicaid	38.46	1.39 %
Total	2,762.03	100 %

Twelve months ended 2025
ACH s Annual Income by Country and Business Segments	Income (in millions $)	% (Profit Margin)
Total	-1,100.64	-

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments	% Y/Y Sales Growth	% Y/Y Income Growth
Capitation agreements	2.52 %	-
Diabetes	0.76 %	-
Sleep therapy	5.28 %	-
Home respiratory therapy	-0.67 %	-
Ostomy	8.63 %	-
Wound care	-2.03 %	-
Urology	8.31 %	-
Other	7.42 %	-
Commercial payors	2.2 %	-
Medicare	7.75 %	-
Medicaid	-4.29 %	-

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.